Assessment of Research Digest Impact for Minority with Prostate Cancer, MiCAP Phase III Study

Not Applicable

Completed

• Conditions: Prostate Carcinoma
• Interventions: Other: Media Intervention; Other: Survey Administration

• Registration Number: NCT05895279
• Lead Sponsor: Mayo Clinic

Brief Summary

This phase III trial determines how well the Minority Prostate Cancer (MiCaP) Research Digest works in providing information to black men about the latest prostate cancer research. MiCaP Research Digest may be an effective method to help people learn about prostate cancer.This goal of this trial is to create educational programming that helps Black men make informed decisions about their prostate healthcare since Black men are diagnosed with prostate cancer more than any other race or ethnicity.

Detailed Description

PRIMARY OBJECTIVE:

I. To develop a research dissemination program, the Minority Prostate Cancer (MiCaP) Research Digest, which will spread information about CaP scientific discoveries, evidence-based interventions, and open clinical trials instantly among black males (BM).

OUTLINE: Participants are randomized to 1 of 2 arms.

ARM I: Participants watch MiCaP Research Digest video on study. Participants complete a survey throughout the trial.

ARM II: Participants watch an alternative video on study. Participants complete a survey throughout the trial.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2021-08-02
• Primary Completion: 2021-10-01
• Study Completion: 2021-10-01
• Study First Submitted: 2023-05-17
• Study First Submitted QC: 2023-05-31
• Study First Posted: 2023-06-08
• Status Verified: 2024-10
• Last Update Submitted: 2024-10-31
• Last Update Posted: 2024-11-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 220

Inclusion Criteria

• Identify as a Black male
• Between the ages of 35 and 70
• For virtual data collection, have access to the internet and Zoom (if joining study online)
• For virtual data collection, reside anywhere in the U.S.
• For in-person data collection, reside in one of the nine (9) catchment areas of the Mayo Clinic Cancer Center: Baker, Duval, Nassau, Clay, St. John's, Putnam, Flagler, Volusia and Brevard

Read More

Exclusion Criteria

• Identify as a race or ethnicity that is not Black
• Identify as female
• Be younger than age 35 and older than age 70
• Lack access to internet and Zoom (if joining study online)

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Alternate Video Group	Media Intervention	Participants watch an alternative video on study. Participants complete a survey throughout the trial.
Alternate Video Group	Survey Administration	Participants watch an alternative video on study. Participants complete a survey throughout the trial.
MiCaP Research Digest Video Group	Survey Administration	Participants watch MiCaP Research Digest video on study. Participants complete a survey throughout the trial.
MiCaP Research Digest Video Group	Media Intervention	Participants watch MiCaP Research Digest video on study. Participants complete a survey throughout the trial.

Primary Outcome Measures

Name	Time	Method
Change in perception of access to medical services and general health	Baseline, 1 hour after video intervention	Using the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 10 questions regarding access to medical services and general health with a yes/no response.
Change in perception in participation with clinical trials about prostate cancer	Baseline, 1 hour after video intervention	Using the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 10 questions regarding views on participating in clinical trials about prostate cancer with a yes/no response.
Change in perception of familiarity with prostate cancer research	Baseline, 1 hour after video intervention	Using the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 5 questions regarding views on participating in clinical trials about prostate cancer with a true/false/don't know response.
Change in perception of familiarity with a research study protocol	Baseline, 1 hour after video intervention	Using the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 5 questions regarding information about a study protocol with a true/false/don't know response.

Trial Locations

Locations (1)

Mayo Clinic in Florida; 🇺🇸 Jacksonville, Florida, United States